JOSE MANUEL VALDIVIELSO REVILLA-rekin lankidetzan egindako argitalpenak (62)

2024

  1. Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort

    Sleep Medicine, Vol. 116, pp. 19-26

  2. Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men

    Clinical Kidney Journal, Vol. 17, Núm. 1

  3. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology, Vol. 15

  4. Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial

    Nutrients, Vol. 15, Núm. 17

  2. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

    Science translational medicine, Vol. 15, Núm. 712, pp. eabn5939

  3. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study

    Atherosclerosis, Vol. 375, pp. 75-83

  4. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project

    Nutrients, Vol. 15, Núm. 1

  5. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

    Atherosclerosis, Vol. 380

2022

  1. Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Elimination of Vitamin D Signaling Causes Increased Mortality in a Model of Overactivation of the Insulin Receptor: Role of Lipid Metabolism

    Nutrients, Vol. 14, Núm. 7

  3. Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: An analysis from the NEFRONA cohort

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 4, pp. 663-672

  4. Prevalence of Obstructive Sleep Apnoea and Its Association With Atherosclerotic Plaques in a Cohort of Subjects With Mild–Moderate Cardiovascular Risk

    Archivos de Bronconeumologia, Vol. 58, Núm. 6, pp. 490-497

  5. Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease

    Nutrients, Vol. 14, Núm. 22

  6. Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis

    eBioMedicine, Vol. 76

2021

  1. Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients

    Clinical Kidney Journal, Vol. 14, Núm. 12, pp. 2591-2599

  2. CYP24A1 and KL polymorphisms are associated with the extent of vascular calcification but do not improve prediction of cardiovascular events

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 11, pp. 2076-2083

  3. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease

    Aging, Vol. 13, Núm. 19, pp. 22690-22709

  4. Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the Ilervas cohort

    Nutrients, Vol. 13, Núm. 3, pp. 1-15

  5. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054